Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Elicera Therapeutics

Market Cap: SEK 162.6m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.5b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Xbrane Biopharma

Market Cap: SEK 310.4m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Bonesupport Holding

Market Cap: SEK 21.0b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BioArctic

Market Cap: SEK 15.4b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

SenzaGen

Market Cap: SEK 142.5m

Provides non-animal tests for assessing a substance’s allergenicity.

Egetis Therapeutics

Market Cap: SEK 1.3b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Modus Therapeutics Holding

Market Cap: SEK 45.5m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

BICO Group

Market Cap: SEK 2.8b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Swedencare

Market Cap: SEK 5.9b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.